Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries

Circulation

Volumn 110, Issue 25, 2004, Pages 3773-3780

  Popma, Jeffrey J ^a   Leon, Martin B ^b   Moses, Jeffrey W ^b   Holmes Jr , David R ^c   Cox, Nicholas ^a   Fitzpatrick, Michelle ^a   Douglas, John ^d   Lambert, Charles ^e   Mooney, Michael ^f   Yakubov, Steven ^g   Kuntz, Richard E ^a,h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

^d EMORY UNIVERSITY HOSPITAL   (United States)

^e Health First   (United States)

^f ABBOTT NORTHWESTERN HOSPITAL   (United States)

^g RIVERSIDE METHODIST HOSPITAL   (United States)

^h HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Coronary disease; Restenosis; Sirolimus; Stents

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; RISK ASSESSMENT;

AGED; ASPIRIN; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES COMPLICATIONS; DOUBLE-BLIND METHOD; DRUG IMPLANTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 19944369733     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000150331.14687.4B     Document Type: Article

References (30)

1. Fishman D, Leon M, Baim D, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994;331:489-495.
3. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002;40:2082-2089.
4. Holmes D, Savage MPS, Lablanche J-M, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial. Circulation 2002;106:1243-1250.
5. O'Malley A, Norman S-L, Kuntz R. Models for multivariate mixed outcomes applications to the estimation of objective performance: coronary-artery stenting. Stat Med. 2003;22:313-336.
6. Baim D, Cutlip D, Midei M, et al. Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001;87:157-162.
7. Baim D, Cutlip D, O'Shaughnessy C, et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001;87:152-156.
8. Holmes D, Lansky A, Kuntz R, et al. The Paragon stent study: a randomized trial of a new martinsitic nitinol stent versus the Palmaz-Schatz (PS)™ stent for the treatment of complex native coronary arterial lesions. Am J Cardiol. 2000;86:1073-1079.
9. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
10. Mehran R, Dangas G, Abizaid A, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-1878.
11. Morice M, Serruys P, Sousa J, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
12. Sousa J, Costa M, Sousa A, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 2003;107:381-383.
13. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
14. Ellis S, Vandormael M, Cowley M, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation. 1990;82:1193-1202.
15. Ryan T, Faxon D, Gunnar R, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12:529-545.
16. Huber MS, Mooney JF, Madison J, et al. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol. 1991;68:467-471.
17. van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform: basic principles and validation results. J Am Coll Cardiol. 1994;24:216-224.
18. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
19. Dussaillant G, Mintz G, Pichard A, et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995;26:720-724.
20. 32P radioactive β-emitting stents. Circulation. 2000;101:2454-2457.
21. 32P radioactive β-emitting stent implantation in patients with coronary artery disease: the Milan Dose-Response Study. Circulation. 2000;101:18-26.
22. Marx S, Marks A. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation. 2001;104:852-855.
23. Sousa J, Costa M, Abizaid A, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001;104:2007-2011.
24. Degertekin M, Serruys P, Foley D, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation. 2002;106:1610-1613.
25. Baumbach A, Bittl JA, Fleck E, et al. Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. Coinvestigators of the U.S. and European Percutaneous Excimer Laser Coronary Angioplasty (PELCA) Registries. J Am Coll Cardiol. 1994;23:1305-1313.
26. Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation. 1997;96:727-732.
27. Slota PA, Fischman DL, Savage MP, et al. Frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty. STRESS Trial Investigators. Am J Cardiol. 1997;79:1104-1106.
28. Vassanelli C, Turri M, Morando G, et al. Coronary arterial aneurysms after percutaneous transluminal coronary angioplasty: a not uncommon finding at elective follow-up angiography. Int J Cardiol. 1989;22:151-156.
29. Walford GD, Midei MG, Aversano TR, et al. Coronary artery aneurysm formation following percutaneous transluminal coronary angioplasty: treatment of associated restenosis with repeat percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn. 1990;20:77-83.
30. Rab ST, King SD, Roubin GS, et al. Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol. 1991;18:1524-1528.